Ethical Human Gene Editing for Sickle Cell Anemia
The biggest ethical worry about human gene editing is that it will be used to make long-lasting, heritable changes at the embryo stage or on germ (sperm or egg) cells. Posts earlier this year have asked whether we should envision a scenario in which human germline gene editing is accepted in a limited number of cases, with the treatment of sickle cell anemia being proposed... // Read More »
Source: blog.bioethics.net - Category: Medical Ethics Authors: Jon Holmlund Tags: Genetics Health Care Stem Cells bioethics biotechnology syndicated Source Type: blogs
More News: Anemia | Biotechnology | Blogging | Genetics | Health | Health Management | Health Medicine & Bioethics Commentators | Medical Ethics | Sickle Cell Anemia | Stem Cell Therapy | Stem Cells